PT3058106T - Marcadores genéticos para aumento de peso induzido por antipsicóticos e métodos para a sua utilização - Google Patents
Marcadores genéticos para aumento de peso induzido por antipsicóticos e métodos para a sua utilizaçãoInfo
- Publication number
- PT3058106T PT3058106T PT14854407T PT14854407T PT3058106T PT 3058106 T PT3058106 T PT 3058106T PT 14854407 T PT14854407 T PT 14854407T PT 14854407 T PT14854407 T PT 14854407T PT 3058106 T PT3058106 T PT 3058106T
- Authority
- PT
- Portugal
- Prior art keywords
- methods
- weight gain
- genetic markers
- induced weight
- antipsychotic induced
- Prior art date
Links
- 230000000561 anti-psychotic effect Effects 0.000 title 1
- 230000002068 genetic effect Effects 0.000 title 1
- 230000004584 weight gain Effects 0.000 title 1
- 235000019786 weight gain Nutrition 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361892094P | 2013-10-17 | 2013-10-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3058106T true PT3058106T (pt) | 2019-05-30 |
Family
ID=52827506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT14854407T PT3058106T (pt) | 2013-10-17 | 2014-10-17 | Marcadores genéticos para aumento de peso induzido por antipsicóticos e métodos para a sua utilização |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10301678B2 (enExample) |
| EP (2) | EP3058106B1 (enExample) |
| JP (1) | JP6524073B2 (enExample) |
| KR (1) | KR102252926B1 (enExample) |
| CN (1) | CN106029901A (enExample) |
| AU (1) | AU2014336928B2 (enExample) |
| CA (1) | CA2943951C (enExample) |
| ES (1) | ES2728072T3 (enExample) |
| IL (1) | IL245159B (enExample) |
| PT (1) | PT3058106T (enExample) |
| SG (1) | SG11201602998QA (enExample) |
| WO (1) | WO2015054792A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3749961A1 (en) * | 2018-02-09 | 2020-12-16 | Metabolomic Diagnostics Limited | Methods of predicting pre term birth from preeclampsia using metabolic and protein biomarkers |
| CN110317868B (zh) * | 2019-08-09 | 2020-05-19 | 新疆医科大学第二附属医院 | 一种基于多基因组合交互作用预测二代抗精神病药物治疗精神分裂症致体重增加分析方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5210015A (en) | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| CA2176348C (en) | 1993-11-12 | 2004-11-02 | Sanjay Tyagi | Hybridization probes for nucleic acid detection, universal stems, methods and kits |
| US20030108938A1 (en) * | 2001-11-06 | 2003-06-12 | David Pickar | Pharmacogenomics-based clinical trial design recommendation and management system and method |
| US8012718B2 (en) | 2006-03-31 | 2011-09-06 | Genomas, Inc. | Physiogenomic method for predicting diabetes and metabolic syndromes induced by psychotropic drugs |
| US20070292962A1 (en) * | 2006-04-10 | 2007-12-20 | Duke University | Methods and compositions for genetic markers for autism |
| US7795033B2 (en) | 2007-03-19 | 2010-09-14 | The United States Of America As Represented By The Department Of Health And Human Services | Methods to predict the outcome of treatment with antidepressant medication |
| US8476012B2 (en) | 2008-04-18 | 2013-07-02 | Genomas, Inc. | Physiogenomic method for predicting metabolic and cardiovascular side effects of thiazolidinediones |
| US8355927B2 (en) | 2010-11-05 | 2013-01-15 | Genomind, Llc | Neuropsychiatric test reports |
| CN104114714A (zh) | 2011-12-14 | 2014-10-22 | 阿斯利康(瑞典)有限公司 | Gabr-a2诊断 |
-
2014
- 2014-10-17 US US15/029,955 patent/US10301678B2/en active Active
- 2014-10-17 CA CA2943951A patent/CA2943951C/en active Active
- 2014-10-17 KR KR1020167012720A patent/KR102252926B1/ko not_active Expired - Fee Related
- 2014-10-17 JP JP2016524143A patent/JP6524073B2/ja not_active Expired - Fee Related
- 2014-10-17 EP EP14854407.5A patent/EP3058106B1/en not_active Not-in-force
- 2014-10-17 ES ES14854407T patent/ES2728072T3/es active Active
- 2014-10-17 WO PCT/CA2014/051000 patent/WO2015054792A1/en not_active Ceased
- 2014-10-17 AU AU2014336928A patent/AU2014336928B2/en not_active Ceased
- 2014-10-17 PT PT14854407T patent/PT3058106T/pt unknown
- 2014-10-17 SG SG11201602998QA patent/SG11201602998QA/en unknown
- 2014-10-17 CN CN201480069450.4A patent/CN106029901A/zh active Pending
- 2014-10-17 EP EP19159011.6A patent/EP3561076A1/en not_active Withdrawn
-
2016
- 2016-04-17 IL IL245159A patent/IL245159B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| JP2016534715A (ja) | 2016-11-10 |
| SG11201602998QA (en) | 2016-05-30 |
| ES2728072T3 (es) | 2019-10-22 |
| KR102252926B1 (ko) | 2021-05-20 |
| AU2014336928B2 (en) | 2020-07-16 |
| CA2943951A1 (en) | 2015-04-23 |
| IL245159B (en) | 2020-10-29 |
| WO2015054792A1 (en) | 2015-04-23 |
| CA2943951C (en) | 2022-05-31 |
| KR20160098188A (ko) | 2016-08-18 |
| EP3058106B1 (en) | 2019-02-27 |
| US10301678B2 (en) | 2019-05-28 |
| IL245159A0 (en) | 2016-06-30 |
| EP3561076A1 (en) | 2019-10-30 |
| EP3058106A1 (en) | 2016-08-24 |
| EP3058106A4 (en) | 2017-06-07 |
| JP6524073B2 (ja) | 2019-06-05 |
| US20160237499A1 (en) | 2016-08-18 |
| CN106029901A (zh) | 2016-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL277917B (en) | jak2 and alk2 inhibitors and their use | |
| ZA201509201B (en) | Soybean transgenic event mon87751 and methods for detection and use thereof | |
| IL234590A0 (en) | Modified pyrazole-containing compounds and their use as pesticides | |
| EP2828258A4 (en) | NOVEL PYRIDOPYRIMIDINE DERIVATIVES AND THEIR USE | |
| GB201318201D0 (en) | Weight Sensing | |
| ZA201405253B (en) | Heterocyclic compounds and methods for their use | |
| ZA201405255B (en) | Heterocyclic compounds and methods for their use | |
| ZA201405257B (en) | Heterocyclic compounds and methods for their use | |
| AP2016009207A0 (en) | Genetic markers and uses therefor | |
| IL244214A0 (en) | Thienopiperidine derivative and its use | |
| IL243433A0 (en) | Titanium bibory layers and their production | |
| IL233652A0 (en) | Converted phenylimidazopyrazoles and their use | |
| DK2708607T3 (da) | Genetiske markører for Myb28 | |
| IL246417B (en) | Genetic markers related to suicide risk and methods of using them | |
| GB201306627D0 (en) | Marker | |
| SG10201708046YA (en) | Nanoprobe-Based Genetic Testing | |
| IL245159B (en) | Genetic markers of an antipsychotic drug for weight gain and methods of using them | |
| EP2971114A4 (en) | METHODS AND COMPOSITIONS FOR ASSESSING GENETIC MARKERS | |
| ZA201600203B (en) | Axmi422 toxin gene and methods for its use | |
| ZA201600204B (en) | Axmi440 toxin gene and methods for its use | |
| EP3065826A4 (en) | Genetic markers of antipsychotic response | |
| GB201204745D0 (en) | Identifying proximity and location | |
| GB201303124D0 (en) | Cell surface markers | |
| GB201303125D0 (en) | Cell surface markers | |
| GB201303127D0 (en) | Cell surface markers |